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oronary Artery Calcification
nd Myocardial Perfusion
issing Cousins or Distant Relatives?*
obert A. Vogel, MD, FACC
altimore, Maryland
ardiologists have more tests, gadgets, and cures than we
now what to do with. We can visualize coronary anatomy
nvasively and soon noninvasively. We can assess ischemia
ith electrocardiograms, radionuclides, echocardiograms,
nd magnetic resonance imaging. We can measure the
emperatures of plaques and peer into atherosclerotic-laden
rterial walls. We even talk to and examine patients.
With all of our tests and gadgets, we still do not precisely
now who is going to experience cardiovascular events and
hen they will occur. Surveying risk factors helps, but they
nly provide us with rough estimates. The majority of
atients suffering a myocardial infarction would not qualify
or cholesterol lowering the day before based on current
uidelines. We urgently need to move from “target lesions”
o “target patients.” Electron beam and multidetector to-
ography have enabled us to measure coronary artery
alcification (CAC) with an ease and accuracy that was
ever possible for those of us who grew up with only
uoroscopy. The question is what does CAC mean? Who
eeds CAC assessed? How should cardiologists treat pa-
ients with very low or very high scores? These are funda-
ental questions for how we manage the epidemic of heart
isease.
See page 1018
In this issue of the Journal, Wang et al. (1) report a close
orrelation between CAC and myocardial perfusion reserve
n 222 men and women assessed with adenosine-induced
yperemia and magnetic resonance imaging. The subjects
ere asymptomatic participants in the 6-center MESA
Multi-Ethnic Study of Atherosclerosis), which is attempt-
ng to place several traditional and evolving markers of
oronary atherosclerosis into prognostic perspective (2).
atients were divided into the following CAC groups using
he Agatston score approach: 0, 1 to 99, 100 to 399, and
400. Overall, perfusion reserve was monotonically lower
cross the increasing CAC levels. A CAC score 400 was
ssociated with an odds ratio 5 times higher for decreased
erfusion reserve compared with a 0 score. Importantly,
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.a
From the Division of Cardiology, Department of Medicine, University of Mary-
and School of Medicine, Baltimore, Maryland.djustment for the traditional Framingham risk factors did
ot substantially modify this association, but it was attenu-
ted in older subjects (65 to 84 years of age) and to some
xtent in women. This study supports the findings of prior
tudies, including a single-center investigation of 411
ostly asymptomatic patients evaluated with electron beam
omputed tomography and single-photon emission com-
uted tomography (3). In this prior study, no patient with
CAC score 10 had stress-induced ischemia, whereas
6% of those with a CAC score 400 had demonstrable
schemia.
What questions does this study answer? Since introduc-
ion, the meaning and clinical value of CAC have been
ighly controversial. The overzealous marketing accompa-
ying its early use gave the technique a black eye. With time
nd the increased access afforded by multidetector scanning,
ts acceptance as a legitimate test has grown. A revised
merican College of Cardiology Clinical Expert Consensus
ocument on CAC is almost finished and will be published
his spring. The current study confirms that CAC is both
natomically and physiologically relevant, especially in
iddle-aged men. It is more than a rough marker of global
therosclerosis burden.
Whatever the technology, we need a screening test to tell
s is who is at risk for a cardiovascular event and what
herapies are appropriate. In our self-imposed silos, invasive
ardiologists only feel comfortable with visualization of
oronary anatomy and preventive cardiologists are content
ith knowing only the risk factor substrate. Each of us has
special hammer and is looking for just the right nail that
ay or may not put the patient back together. Neither of
hese approaches makes total sense. We do not need to find
esions in asymptomatic patients that are not going to
upture. This limitation of the anatomist’s viewpoint needs
o be addressed before we are able to assess everyone’s
oronary anatomy thanks to computed tomographic angiog-
aphy, followed immediately by stenting every bump in
ight. Even as a preventive cardiologist, I know that many of
y healthy patients will not benefit from the intensive risk
actor modification they are receiving. My mother died at
ge 96 without any evidence of cardiovascular disease, but
ith an untreated cholesterol value of 350 mg/dl. She
bviously did not need treatment. We need to focus on the
undamental question, who is at risk and who needs
reatment?
Coronary perfusion indexes, such as stress-induced isch-
mia and perfusion reserve, provide that advantage. We
nce thought that these indexes simply measure the severity
f upstream stenoses. Even at that time, this concept did not
ake complete sense because we knew that similar-grade
tenoses produced very different consequences to perfusion
eserve (4). We now know that functional indexes also
eflect coronary endothelial function and microvessel dis-
ase, both of which correlate with ongoing atherosclerotic
ctivity (5). Atherosclerotic activity is closer to our goal of
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Editorial Comment September 5, 2006:1027–8nowing who will have an event. Even nonlocalizing mea-
ures of inflammation and endothelial dysfunction seem to
rovide prognostic information (6,7). Numerous clinical
rials support the concept that patients with demonstrable
yocardial ischemia are at increased risk and derive greater
enefit from coronary intervention (8).
Clearly, CAC occurs only in the setting of atherosclero-
is. It does not correlate closely with stenosis severity, but
robably is a better index of global atherosclerotic burden.
or patient prognosis, this is an advantage because disease
urden rather than stenosis severity predicts outcome.
The present report suggests that CAC may be an appro-
riate screen for a true cross-section of the population. Prior
tudies were generally limited to selected cohorts. It con-
rms that CAC measures more than atherosclerosis, namely
ts associated functional impairment. This capacity and its
bility to assess global disease burden may be the major
easons why CAC adds independent prognostic informa-
ion in almost every study to date (9). This present study
laces reservations on CAC as a prognostic marker in older
nd possibly female patients, which supports our existing
nderstanding.
Some details of this report deserve comment. The largest
ntergroup difference in perfusion reserve in middle-aged
ubjects is between those with scores 100 to 399 and 400.
ery high scores are associated with considerable functional
mpairment. This finding suggests that very high CAC
cores carry the greatest independent prognostic relevance,
s has been observed in outcome trials (10). At the other end
f the CAC spectrum, there is also considerable difference
n perfusion reserve between those with 0 and low scores.
hether this observation correctly implies that we can
ithhold therapy from those middle-aged patients with no
AC is a critical question, but one beyond the scope of this
tudy.
The present study does not answer our ultimate ques-
ions. We will have to wait for the completion of the MESA
rial to learn how good CAC really is as a population
creening test for actual coronary risk, especially compared
ith the myriad traditional and evolving risk markers, which
re also being investigated. The study tells us nothing about
ow we should treat a patient with absent, medium, or high
AC scores. Because it did not include subjects under 45ears old, it cannot tell us when we might wish to start
ssessing CAC. Finally, the paper reports that left anterior
escending CAC is related to segmental perfusion reserve,
ut does not provide the actual data. This regional associ-
tion hints that CAC may predict the need for specific
rtery intervention. If confirmed, this would certainly take
AC to a level beyond that of a much-maligned rough
lobal screen. Despite limitations, this article is a meaning-
ul step forward and tells us that CAC may be more than an
conomically rewarding curiosity. It may be of real value as
coronary screen in appropriate populations.
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